ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,212Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 670

$752K Total Retail Price of All Prescriptions

Rank: 80 out of 670

323 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,359 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 508 396 1 4
OMEPRAZOLE 388 326 2 5
LEVOTHYROXINE SODIUM 321 271 3 2
LISINOPRIL 267 203 4 3
METFORMIN HCL 221 173 5 8
POTASSIUM CHLORIDE 215 195 6 16
FUROSEMIDE 207 187 7 6
ZOLPIDEM TARTRATE 199 168 8 23
WARFARIN SODIUM 197 158 9 13
HYDROCODONE-ACETAMINOPHEN 165 136 S3 10 1
METOPROLOL TARTRATE 165 141 10 9
HYDROCHLOROTHIAZIDE 151 139 12 10
CITALOPRAM HBR 150 127 13 20
NEXIUM 139 95 14 14
AMLODIPINE BESYLATE 132 88 15 7
JANUVIA 131 104 16 53
ATENOLOL 128 91 17 17
ISOSORBIDE MONONITRATE ER 119 113 18 45
CLOPIDOGREL 116 102 19 24
TRAMADOL HCL 116 85 19 21
GABAPENTIN 112 84 21 11
METOPROLOL SUCCINATE 110 88 22 12
FLUTICASONE PROPIONATE 107 88 23 37
FAMOTIDINE 106 89 24 99
CRESTOR 98 85 25 18
ZETIA 96 80 26 66
AZITHROMYCIN 93 74 27 35
SYNTHROID 85 63 28 47
GLIMEPIRIDE 81 73 29 32
PLAVIX 78 72 30 34
ENALAPRIL MALEATE 74 65 31 49
RANITIDINE HCL 72 65 32 25
PANTOPRAZOLE SODIUM 70 59 33 41
ATORVASTATIN CALCIUM 69 61 34 15
NIASPAN 68 63 35 116
LEVOFLOXACIN 67 55 36 88
SERTRALINE HCL 63 48 37 22
SINGULAIR 62 53 38 56
VITAMIN D2 60 60 39 160
METHYLPREDNISOLONE 59 46 40 120
FLUCONAZOLE 59 40 40 140
ALLOPURINOL 58 49 42 38
ADVAIR DISKUS 58 55 42 42
DIOVAN 54 53 44 48
PREDNISONE 52 38 45 40
LOSARTAN POTASSIUM 52 44 45 26
LORAZEPAM 51 50 47 171
TAMSULOSIN HCL 50 41 48 30
AMOX TR-POTASSIUM CLAVULANATE 50 39 48 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.